Good morning. Thank you, Christine Simmon, for the introduction, and thank you, as well, to the Food and Drug Law Institute for inviting me to speak this morning. I am grateful for the opportunity to open the Enforcement, Litigation and Compliance Conference, and I look forward to hearing from many experienced and accomplished regulators, litigators and academics on emerging trends and issues in enforcement and compliance.